Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
38.00
Nov 20 • 3:59 PM ET Dollar change-2.27 Percentage change(-5.64%)
Aftermarket Close
38.93
Aftermarket • 7:58 PM ET Dollar change+0.93 Percentage change(2.45%)
Category
US Equities - Industry Sector
Sponsor
ARK Funds
Fund Family
Index
-
Index Weighting
Active/Passive
Expense
0.75%
Inverse/Leveraged
IPO
Oct 31, 2014
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
Tags
-
Sector/Theme
Region
SMA20
-18.12%
SMA50
-22.40%
SMA200
-0.86%
Return% 1Y
39.40%
Return% 3Y
12.60%
Return% 5Y
-12.23%
Return% 10Y
Return% SI
Flows% 1M
3.54%
Flows% 3M
3.13%
Flows% YTD
11.26%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
35
AUM
1.63B
NAV/sh
52W High
58.83 -35.41%
52W Low
24.60 54.47%
Volatility
5.18% 5.55%
ATR (14)
2.64
RSI (14)
31.02
Beta
1.79
Rel Volume
0.98
Avg Volume
5.04M
Volume
4,940,929
Perf Week
-12.04%
Perf Month
-20.62%
Perf Quarter
-20.85%
Perf Half Y
23.90%
Perf YTD
31.17%
Perf Year
39.65%
Perf 3Y
34.85%
Perf 5Y
-44.20%
Perf 10Y
119.69%
Prev Close
40.27
Price
38.00
Change %
-5.64%
ARK Genomic Revolution ETF seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.